Free Trial
TSE:CNJ

27773 (CNJ.TO) (CNJ) Stock Price, News & Analysis

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)
Free CNJ Stock Alerts
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About 27773 (CNJ.TO)

Cangene Corporation (Cangene) is a biopharmaceutical company in the business of developing, manufacturing, and commercializing products and technologies for global markets. It operates in two segments: biopharmaceutical operations and contract services. The biopharmaceutical operations segment consist of sales of approved products and non- specialty plasma. The contract-services segment consists of third-party contract-manufacturing revenues at the Company’s Winnipeg facilities, as well as at Cangene bioPharma in Baltimore. It also provides commercial contract-manufacturing services, primarily through a United States-based subsidiary. The Company’s products include Rho(D) Immune Globulin (Human) for Injection (WinRho) SDF, Hepatitis B Immune Globulin (Human) Injection (HepaGam B) and Varicella Zoster Immune Globulin (Human) (VariZIG). In February 2014, Emergent BioSolutions Inc completed the acquisition of Cangene.

CNJ Stock News Headlines

January 4, 2024 | forbes.com
Most And Least Expensive Vehicles To Insure 2024
July 19, 2023 | morningstar.com
Goldman Sachs FS Government Svc
See More Headlines
Receive CNJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 27773 (CNJ.TO) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
TSE:CNJ
CUSIP
N/A
CIK
N/A
Web
N/A
Phone
+1-204-2754200
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • R. Craig Baxter
    Chairman of the Board
  • John A. Sedor (Age 72)
    President, Chief Executive Officer, Director
  • Jeffrey Lamothe
    Chief Financial Officer
  • Gary Clyde Floyd
    Chief Operating Officer
  • Laura Saward
    Chief Scientific Officer
  • Michael D. Adelman
    Vice President - Commercial Operations
  • Francis St. Hilaire
    Vice President, General Counsel, Secretary
  • Les Deezar
    Vice President - Human Resources
  • Chris Sinclair
    Vice President - Strategic Planning
  • Kevin G. Taylor
    Vice President - Business Development

CNJ Stock Analysis - Frequently Asked Questions

How do I buy shares of 27773 (CNJ.TO)?

Shares of CNJ stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:CNJ) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Prepare for a recession unlike any other
American Hartford Gold Group
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars
GoldenCrest Metals